Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression (Q46797116)

25 December 2017

title

Homeostatic repopulation by CD28-CD8+ T cells in alemtuzumab-depleted kidney transplant recipients treated with reduced immunosuppression (English)

1 reference

25 December 2017

1 reference

P Trzonkowski

1 reference

25 December 2017

M Zilvetti

1 reference

25 December 2017

S Chapman

1 reference

25 December 2017

J Wieckiewicz

1 reference

25 December 2017

A Sutherland

1 reference

25 December 2017

P Friend

1 reference

25 December 2017

K J Wood

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

25 December 2017

American Journal of Transplantation

published in

1 reference

25 December 2017

volume

1 reference

25 December 2017

issue

1 reference

25 December 2017

page(s)

338-347

1 reference

25 December 2017

Homeostatic proliferation is a barrier to transplantation tolerance

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Development of tolerogenic strategies in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation--efficacy and safety at five years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Will telomere erosion lead to a loss of T-cell memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Replicative senescence in the immune system: impact of the Hayflick limit on T-cell function in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Non-malignant clonal expansions of CD8+ memory T cells in aged individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Molecular characterization of allospecific T suppressor and tolerogenic dendritic cells: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02078.X

10.1111/J.1600-6143.2007.02078.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

release_wsf2ivvza5f3lmylybxb4vudjq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wsf2ivvza5f3lmylybxb4vudjq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017